Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Por Roy, V., LaPlant, B. R., Gross, G. G., Bane, C. L., Palmieri, F. M.
Publicado em 2009

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Por Inwards, D. J., Fishkin, P. A., LaPlant, B. R., Drake, M. T., Kurtin, P. J., Nikcevich, D. A., Wender, D. B., Lair, B. S., Witzig, T. E.
Publicado no Ann Oncol (2014)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

Por Inwards, D J, Fishkin, P A, LaPlant, B R, Drake, M T, Kurtin, P J, Nikcevich, D A, Wender, D B, Lair, B S, Witzig, T E
Publicado no Ann Oncol (2019)

Elevated Soluble IL-2Rα, IL-8, and MIP-1β Levels are Associated with Inferior Outcome and are Independent of MIPI Score in Patients with Mantle Cell Lymphoma

Por Sonbol, M. B., Maurer, M. J., Stenson, M. J., Allmer, C., LaPlant, B. R., Weiner, G. J., Macon, W. R., Cerhan, J. R., Witzig, T. E., Gupta, M.
Publicado no Am J Hematol (2014)

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia

Por Sfeir, J G, Drake, M T, LaPlant, B R, Maurer, M J, Link, B K, Berndt, T J, Shanafelt, T D, Cerhan, J R, Habermann, T M, Feldman, A L, Witzig, T
Publicado no Blood Cancer J (2017)

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Por Witzig, T E, Reeder, C B, LaPlant, B R, Gupta, M, Johnston, P B, Micallef, I N, Porrata, L F, Ansell, S M, Colgan, J P, Jacobsen, E D, Ghobrial, I M, Habermann, T M
Publicado em 2011

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Por Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, Giovannino, Habermann, T. M., Witzig, T. E., Vitolo, U., Nowakowski, G. S.
Publicado no Blood Cancer J (2018)